These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38926638)

  • 1. Detecting agitation and aggression in persons living with dementia: a systematic review of diagnostic accuracy.
    Wong B; Wu P; Ismail Z; Watt J; Goodarzi Z
    BMC Geriatr; 2024 Jun; 24(1):559. PubMed ID: 38926638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agitation and aggression in people living with dementia and mild cognitive impairment in shared-housing arrangements - validation of a German version of the Cohen-Mansfield Agitation Inventory-Short Form (CMAI-SF).
    Kratzer A; Scheel-Barteit J; Altona J; Wolf-Ostermann K; Graessel E; Donath C
    Health Qual Life Outcomes; 2023 May; 21(1):51. PubMed ID: 37248478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Cohen-Mansfield Agitation Inventory Observational (CMAI-O) tool.
    Griffiths AW; Albertyn CP; Burnley NL; Creese B; Walwyn R; Holloway I; Safarikova J; Surr CA
    Int Psychogeriatr; 2020 Jan; 32(1):75-85. PubMed ID: 30968783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting agitation and aggression in people with dementia using sensors-A systematic review.
    Khan SS; Ye B; Taati B; Mihailidis A
    Alzheimers Dement; 2018 Jun; 14(6):824-832. PubMed ID: 29571749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.
    De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M
    J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia.
    Ismail Z; Emeremni CA; Houck PR; Mazumdar S; Rosen J; Rajji TK; Pollock BG; Mulsant BH
    Am J Geriatr Psychiatry; 2013 Jan; 21(1):78-87. PubMed ID: 23290205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.
    Livingston G; Kelly L; Lewis-Holmes E; Baio G; Morris S; Patel N; Omar RZ; Katona C; Cooper C
    Health Technol Assess; 2014 Jun; 18(39):1-226, v-vi. PubMed ID: 24947468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.
    Stella F; Forlenza OV; Laks J; de Andrade LP; Avendaño MA; Sé EV; Cação Jde C; Lyketsos CG; de Medeiros K
    Int Psychogeriatr; 2013 Sep; 25(9):1503-11. PubMed ID: 23763895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia.
    Zuidema SU; Derksen E; Verhey FR; Koopmans RT
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):632-8. PubMed ID: 17136713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate preparations for agitation in dementia.
    Baillon SF; Narayana U; Luxenberg JS; Clifton AV
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003945. PubMed ID: 30293233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agitation Detection in People Living with Dementia using Multimodal Sensors.
    Khan SS; Spasojevic S; Nogas J; Ye B; Mihailidis A; Iaboni A; Wang A; Martin LS; Newman K
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():3588-3591. PubMed ID: 31946653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Efficacy of Interventions for Aggressive and Agitated Behaviors in Dementia: A Systematic Review and Network Meta-analysis.
    Watt JA; Goodarzi Z; Veroniki AA; Nincic V; Khan PA; Ghassemi M; Thompson Y; Tricco AC; Straus SE
    Ann Intern Med; 2019 Nov; 171(9):633-642. PubMed ID: 31610547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care-Delivery Interventions to Manage Agitation and Aggression in Dementia Nursing Home and Assisted Living Residents: A Systematic Review and Meta-analysis.
    Jutkowitz E; Brasure M; Fuchs E; Shippee T; Kane RA; Fink HA; Butler M; Sylvanus T; Kane RL
    J Am Geriatr Soc; 2016 Mar; 64(3):477-88. PubMed ID: 27000321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Jajawi S; Spyridi S; Sayal K; Jayaram MB
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD008074. PubMed ID: 29308601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria.
    De Mauleon A; Ismail Z; Rosenberg P; Miller D; Cantet C; O'Gorman C; Vellas B; Lyketsos C; Soto M
    Alzheimers Dement; 2021 Oct; 17(10):1687-1697. PubMed ID: 34132461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.